Daniel L. Rudnicki, Ph.D.
Affiliations: | 2012 | Chemistry | University of Colorado, Boulder, Boulder, CO, United States |
Area:
General Chemistry, Pharmaceutical Chemistry, Pharmacy, OncologyGoogle:
"Daniel Rudnicki"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Tad Harbison Koch | grad student | 2012 | CU Boulder | |
| (Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Barthel BL, Rudnicki DL, Kirby TP, et al. (2012) Synthesis and biological characterization of protease-activated prodrugs of doxazolidine. Journal of Medicinal Chemistry. 55: 6595-607 |
| Barthel BL, Zhang Z, Rudnicki DL, et al. (2009) Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine. Journal of Medicinal Chemistry. 52: 7678-88 |
| Koch TH, Barthel BL, Kalet BT, et al. (2008) Anthracycline-formaldehyde conjugates and their targeted prodrugs. Topics in Current Chemistry. 283: 141-70 |